
Buy Cardiogen Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.

Buy Cardiogen Research Peptide
Supplied as a lyophilized powder and independently verified to ≥98% purity by HPLC and MS-UPLC analysis.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
HPLC Verified
≥98% purity
Lyophilised
Powder format
Express Shipping
Cold-chain included
COA Available
Every batch
Ships Next Day
Orders confirmed before 12pm EST ship the same business day; orders after 12pm EST ship the next business day. Monday to Friday.
Verify Batch
Lot-level COA, Batch DF/CDG/062026
What is Cardiogen?
Cardiogen is a synthetic four-amino-acid peptide (Ala-Glu-Asp-Arg) from the Russian peptide bioregulator program, designed to target heart tissue. It is studied in laboratory research for its effects on heart-muscle cell signaling and gene activity.
- A short synthetic peptide (Ala-Glu-Asp-Arg) from the Russian bioregulator program
- Studied in laboratory research for its effects on heart-muscle cell signaling and gene activity
- One of a family of short peptides each studied in a specific tissue type
- Investigated alongside Bronchogen, Epithalon and other organ-specific bioregulators
For research use only. Not approved for human therapeutic use.
Cardiogen, also known by its tetrapeptide designation AEDR (Ala-Glu-Asp-Arg), is a synthetic tetrapeptide bioregulator with a molecular weight of 489.49 g/mol. Developed at the Saint Petersburg Institute of Bioregulation and Gerontology as part of the Khavinson peptide bioregulator series, Cardiogen was designed based on peptide fractions associated with cardiac tissue. Its sequence, Ala-Glu-Asp-Arg, extends the AED core motif shared across the bioregulator series with a C-terminal arginine residue, a basic amino acid containing the guanidinium group. This structural variation within the AED-based tetrapeptide series, where the C-terminal residue defines organ specificity, is a distinctive feature of the Khavinson bioregulator design framework. Produced via solid-phase peptide synthesis, Cardiogen is associated with cardiac tissue gene expression and myocardial signaling pathways.
Cardiogen belongs to the ultra-short peptide bioregulators developed by Professor Vladimir Khavinson. In common with related bioregulator peptides such as Epithalon (AEDG), Pinealon (EDR) and Cortagen (AEDP), Cardiogen has been proposed to exert its biological activity through direct, sequence-selective interaction with DNA rather than conventional cell-surface receptor-mediated signaling. In vitro research using organotypic culture has documented that Cardiogen stimulates the development of myocardial tissue explants, with a robust proliferative effect observed consistently in preparations from both young and old rats [1]. At the level of the aging cardiovascular system, peptide bioregulators of this class have been reviewed in the broader context of cellular senescence and inflammaging in cardiovascular tissue [2], making Cardiogen a reference compound in preclinical cardiovascular research examining ultra-short peptide-bioregulator modulation of myocardial tissue development, cardiac signaling, and age-related changes in cardiovascular tissue.
Cardiogen is produced to research-grade standards and independently verified by third-party HPLC and MS-UPLC analysis before dispatch. Vials are vacuum sealed and stored in a temperature controlled, monitored cold storage system. Certificates of Analysis are available to view and download directly on the product page.
Sold strictly for in vitro research purposes only. Not for human consumption. Intended for use by qualified researchers in laboratory settings only.
References
Scientific Review

Dr. Martina Rossi, PhD
Scientific Contributor and Reviewer
Reviewed for scientific accuracy, 14 June 2026
Lyophilised powder: store at -20 °C or below, away from light and moisture. Once reconstituted in an appropriate laboratory diluent (e.g. sterile water, PBS, or assay buffer), store at 2–8 °C and use within the validated period for your protocol. Do not refreeze.
What Researchers Say
Sign in to leave a reviewNo reviews yet. Be the first to share your research experience.
Frequently Asked Questions
Research
Khavinson Bioregulators: Investigations on Short Peptide Research
Select Size
Quality Guaranteed
Every batch is HPLC-tested to ≥98% purity. Certificate of Analysis available on this page; MSDS available on request.






